News

TOGA’s Scientific Committee Meeting Recap – August 2024

A re-cap of the Scientific Committee meeting in August 2024.

  • Clinical trial concepts in mesothelioma, thymoma*, and supportive care for lung cancer patients were presented and endorsed.
  • The supportive care concepts addressed fear of cancer recurrence and screening for unmet supportive care needs in people living with lung cancer.
  • A study examining differences in tumour tissue and the impact on survival and relapse was also endorsed. This study will use the data and sample sets collected as part of TOGA’s ASPiRATION study. The ASPiRATION study offered comprehensive genomic profiling to all metastatic NSCLC patients so they could be matched to options offering therapies targeted to any particular mutations that drove cancer growth. This study is now closed to recruitment, but contributed to the approval of a similar type of test under Medicare.

TOGA is always looking for research to review and endorse. If you would like to submit a proposal for peer-review and endorsement, you can read more about the process here.  If you have a proposal due for competitive funding before that date and would like TOGA peer-review and endorsement, please contact info@thoraciconcology.org.au and include the date of your submission.

Share this

Facebook
Twitter
LinkedIn
Discover the major advances from TOGA ASM 2026, including lung cancer screening, precision medicine, immunotherapy, survivorship and multidisciplinary care shaping the future of thoracic oncology.
Professor Robert Stirling OAM devoted his career to improving the lives of people with lung cancer through clinical excellence, research, education and compassionate leadership.
TOGA is pleased to announce the latest appoints for our Scientific Committee.
Discover TOGA’s FY25 highlights, including the new Strategic Plan, clinical trial milestones and record membership growth across Australia and New Zealand.
The Preventative and Quality Care Working Group represents TOGA’s commitment to improving the outcomes of thoracic cancers.
TOGA’s Working Groups are evolving to better reflect where thoracic cancer research is heading: From prevention and early detection through to advanced disease and living
Let's take a moment to celebrate the incredible guests, ground breaking discussions, and dedicated listeners that made 2025 our most successful year yet.
If you are interested in joining TOGA on a Committee, please submit your nominations by 30 January 2026
Research advances only improve outcomes when they are accessible to patients. TOGA drives change in lung cancer care by advocating through stakeholder submissions, including PBS.......
A re-cap of the Scientific Committee meeting in August 2025 and the year to date.
Celebrating TOGA's leadership transition: We honour the service of our past Board members and welcome the new Chair and Directors who will chart TOGA’s future.
Precision medicine has revolutionised lung cancer treatment by matching therapies to a patient’s genetic profile. Learn more.....
An in-depth recap of the 2025 Annual Scientific Meeting. Read about the key takeaways, a new strategic plan, and who took home the top awards.
TOGA’s 2025–2028 Strategic Plan sets a bold direction to expand research, grow leadership, and improve care for people with thoracic cancers.
TOGA is proud to welcome three extraordinary individuals as Life Members.
Designing fairer lung cancer clinical trials for all Australians. Learn how TOGA is improving inclusion in research through consumer involvement, broader trial access, and more
Prof Ben Solomon and Nick Pavlakis, have secured a landmark $14,707,962 in funding for the ASPiRATION-2 Liquid clinical trial.
TOGA's 2024 Annual Report is here detailing a year of significant progress and growth in membership, engagement, and research funding.
TOGA is excited to announce that it has been awarded a grant as part of the 2024-2027 Support for Cancer Clinical Trials Program.
We are pleased to announce some exciting changes to the TOGA Board of Directors.
We’ve all seen the exciting ‘practice-changing’ results presented at conferences like ESMO 2023. But how do these new cancer treatments become available for everyday use
The Inspirational Research Grant has been created from philanthropic donations to increase research into prevention, treatment, or improved lives of those living with thoracic cancers.
The 2023 Annual Scientific Meeting showcased the latest lung cancer research highlighting the importance of a multidisciplinary approach.